SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-037761
Filing Date
2019-06-27
Accepted
2019-06-27 08:08:15
Documents
9
Period of Report
2019-06-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-12168_18k.htm 8-K 38321
2 EX-10.1 a19-12168_1ex10d1.htm EX-10.1 124871
3 EX-10.2 a19-12168_1ex10d2.htm EX-10.2 83816
4 EX-10.3 a19-12168_1ex10d3.htm EX-10.3 33932
5 EX-10.4 a19-12168_1ex10d4.htm EX-10.4 129816
6 EX-99.1 a19-12168_1ex99d1.htm EX-99.1 13158
7 GRAPHIC g121681ko01i001.jpg GRAPHIC 3486
8 GRAPHIC g121681kki001.jpg GRAPHIC 3486
9 GRAPHIC g121681mmi001.jpg GRAPHIC 3445
  Complete submission text file 0001104659-19-037761.txt   440126
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 19922991
SIC: 2836 Biological Products, (No Diagnostic Substances)